Envision Solutions Spotlight:
Preserving The Power Of Pharma-Non-Profit Cause Alliances
Price: $59.95

Overview

For decades, non-profit organizations such as the American Heart Association and the National Kidney Foundation have engaged in mutually beneficial partnerships or cause alliances with drug firms. 

In general, these pairings have been viewed favorably because they have educated the public and improved medical care. 

Today however, the landscape is changing. The public deeply mistrusts the pharmaceutical industry.  Also, critics have accused non-profits of working with drug firms to "disease monger."  According to the journal PLoS Medicine, this refers to the "selling of sickness that widens the boundaries of illness and grows the markets for those who sell or deliver treatments."  These trends threaten to diminish the credibility and effectiveness of pharma-non-profit cause alliances. 

This report is designed to help executives from pharmaceutical companies and non-profits (especially patient groups and medical societies):

• Understand the evolution of the disease mongering debate in the media and why it is important

• Recognize how disease mongering-related media coverage has influenced reporting about cause alliances

• Dive into the latest public opinion data on pharmaceutical industry support of non-profits

• Learn why preserving the power of cause alliances will require proactive communication and increased transparency

Learn More

Download Complimentary Preview Of Report: Click here

Table Of Contents: Click here
Press Release: Click here

Purchase This Report

Adobe Acrobat Reader 5.0 or later required. Click here to download latest free Reader.

For your protection, all payments are processed via
SSL 128 bit encryption.

Please click here to learn about our other Spotlight reports.